Inventor
Bo Gyou Kim
Inventor
Seoul, KR
Overview
Patents· 15 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
C07Kprimary
C07KPeptides22%
A61KPreparations for medical, dental or toiletry purposes20%
G01NInvestigating or analysing materials by determining their chemical or physical properties15%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations13%
C12QMeasuring or testing processes involving enzymes, nucleic acids or microorganisms9%
C12NMicroorganisms or enzymes4%
C09KMaterials for miscellaneous applications, not provided for elsewhere2%
C23CCoating metallic material2%
G02FOptical devices or arrangements for the control of light by modification of the optical properties of the media of the elements involved therein2%
G11CStatic stores2%
PatentTitleYear
11,043,533Switch and method for fabricating the same, and resistive memory cell and electronic device, including the same202110,928,699Electrochromic device202110,578,621Biomarker PNCK for predicting effect of a dual-targeting agent202010,246,507Polypeptide, anti-VEGF antibody, and anti-c-Met/anti-VEGF bispecific antibodies comprising the same20199,956,244Biomarker Hsp90 for predicting effect of a c-Met inhibitor20189,943,596Combination therapy using dual inhibitor of c-MET and EGFR and IGF-1R inhibitor20189,850,537Biomarker TFF1 for predicting effect of C-MET inhibitor20179,808,507'Anti-c-Met/anti-Ang2 bispecific antibody'20179,567,641'Combination therapy for the treatment of cancer using an anti-C-met antibody'20179,535,055'Marker for determining effects of anti-c-Met antibody and method of determining effects of anti-c-Met antibody using the marker'20179,233,155'Method of treating solid cancers using anti-c-Met antibody and sorafenib combination therapy'20169,213,031'Use of Cbl as biomarker for identifying subject suitable for treatment with anti-c-Met antibody'20159,213,032'Use of LRIG1 as a biomarker for identifying a subject for application of anti-c-Met antibodies'20159,192,666'Method of treating cancer using anti-c-Met antibody and FGFR inhibitor combination therapy'20158,501,917'Anti c-Met antibody and uses thereof'2013Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2013–2020Patents assigned to SAMSUNG ELECTRONICS CO LTD (13)· patent assignee history
2013–2020Based in Seoul, KR· patent location history
2017Patents assigned to UNIV GEORGETOWN (1)· patent assignee history
2021Patents assigned to LEAPHIGH INC (1)· patent assignee history
2021Patents assigned to SK HYNIX INC (1)· patent assignee history
2021Based in Suwon-si, KR· patent location history
2021Based in Gyeonggi-do, KR· patent location history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| SAMSUNG ELECTRONICS CO LTD | 13 | 2013–2020 |
| LEAPHIGH INC | 1 | 2021 |
| SK HYNIX INC | 1 | 2021 |
| UNIV GEORGETOWN | 1 | 2017 |
Locations
| Location | Patents | Span |
|---|---|---|
| Seoul, KR | 13 | 2013–2020 |
| Suwon-si, KR | 1 | 2021 |
| Gyeonggi-do, KR | 1 | 2021 |